sodium selenate 0.055 MG
RxNorm concept 891713, clinical drug component (scdc).
- RxCUI
- 891713
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/891713 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- ascorbic acid 200 MG / beta carotene 1000 UNT / cuprous oxide 2 MG / dl-alpha tocopheryl acetate 60 UNT / lutein 2 MG / sodium selenate 0.055 MG / zinc oxide 40 MG Oral Tablet (SCD, constitutes)
- ascorbic acid 200 MG / beta carotene 1000 UNT / cuprous oxide 2 MG / dl-alpha tocopheryl acetate 60 UNT / lutein 2 MG / sodium selenate 0.055 MG / zinc oxide 40 MG Oral Tablet [Ocuvite] (SBD, constitutes)
- sodium selenate (IN, has ingredient)
- ascorbic acid 200 MG / beta carotene 1000 UNT / cuprous oxide 2 MG / dl-alpha tocopheryl acetate 60 UNT / lutein 2 MG / sodium selenate 0.055 MG / zinc oxide 40 MG [Ocuvite] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 891713 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/891713 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 891713. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.